|
|
| Quarterly Results |
|
| Pfizer Ltd | | Industry : Pharmaceuticals - Multinational | Chairman : Pradip P Shah | | Home : MNC Associate | Book Value: 715.4426217 | | BSE Code : 500680 | Market Cap: 19268.72 | | NSE Code : PFIZER | P / E : 37.94 | |
| |
|
|
|
|
|
|
| (Rs in Cr.) |
|
|
| Type | 3Qtr | 2Qtr | 1Qtr | 4Qtr | | Net Sales | 539.97 | 575.21 | 531.36 | 572.64 | | Other Income | 43.80 | 36.07 | 33.46 | 31.38 | | Total Income | 583.77 | 611.28 | 564.82 | 604.02 | | Total Expenditure | 387.42 | 392.60 | 420.65 | 410.36 | | Operating Profit | 196.35 | 218.68 | 144.17 | 193.66 | | Interest | 2.86 | 2.73 | 2.87 | 2.53 | | Gross Profit | 193.49 | 215.95 | 141.30 | 191.13 | | Depreciation | 17.55 | 15.43 | 15.55 | 26.41 | | Tax | 29.17 | 47.34 | 33.43 | 66.60 | | Deferred Tax | 16.79 | 4.22 | -1.21 | -31.53 | | Reported Profit After Tax | 129.98 | 148.96 | 93.53 | 129.65 |
|
|
|
|
|